Skip to main content
. 2021 Oct 23;11(1):145–163. doi: 10.1007/s40121-021-00553-0

Table 2.

Pulmonary function and 6MWT of surviving HCWs

Characteristics All Group (n = 303)
HCWs with mild/moderate illness (n = 113) HCWs with critical/severe illness (n = 190) p value
Age, median (IQR), years 39.00 (33.00–48.00) 38.00 (31.00–46.00) 39.00 (34.00–49.00) 0.0476
Sex
 Female, n (%) 244 (80.53) 91 (80.53) 153 (80.53) 0.9992
BMI, median (IQR), kg/m2 23.44 (21.30–25.71) 22.72 (20.96–24.99) 24.00 (21.48–25.97) 0.0093
Spirometry, median (IQR)
 FEV1 (l), % predicted 98.00 (89.80–106.00) 97.90 (90.20–105.30) 98.00 (89.60–106.00) 0.9099
  < 80% pred, n/N (%) 23 (7.59) 11 (9.73) 12 (6.32) 0.2772
 VCmax (l), % predicted 104.90 (97.70–112.80) 105.10 (96.20–111.40) 104.90 (97.90–113.60) 0.4297
 FVC (l), % predicted 106.70 (99.00–115.40) 106.50 (97.90–114.40) 107.05 (99.40–115.70) 0.2603
  < 80% pred, n/N (%) 7 (2.31) 4 (3.54) 3 (1.58) 0.2719
 FEV1/FVC, % 77.90 (74.46–81.69) 78.73 (74.30–81.89) 77.53 (74.56–81.43) 0.191
  < 70%, n/N (%) 24 (7.92) 9 (7.96) 15 (7.89) 0.9826
 FEV1/VCmax, % 77.58 (74.03–81.33) 77.97 (74.30–81.57) 77.06 (73.88–80.89) 0.1456
 PEF (l/s), % predicted 104.90 (95.10–114.50) 104.30 (93.80–110.20) 105.60 (95.70–116.10) 0.0252
 MEF75 (l/s), % predicted 99.60 (85.70–113.50) 98.70 (84.10–110.80) 100.55 (86.00–113.70) 0.4874
  < 65% pred, n/N (%) 14 (4.62) 3 (2.65) 11 (5.79) 0.2088
 MEF50 (l/s), % predicted 71.90 (59.90–86.50) 70.90 (60.60–86.50) 72.25 (59.00–86.00) 0.8654
  < 65% pred, n/N (%) 113(37.29) 44(38.94) 69 (36.32) 0.6481
 MEF25 (l/s), % predicted 49.40 (38.20–62.20) 53.70 (40.40–63.00) 47.80 (37.30–61.80) 0.0887
Lung volume, median (IQR)
 TLC (l) % predicted 96.70 (91.00–103.10) 97.10 (91.10–103.20) 96.65 (90.90–102.90) 0.8388
  < 80% pred, n/N (%) 16 (5.28) 6 (5.31) 10 (5.26) 0.986
 RV (l) % predicted 95.50 (84.60–105.60) 98.30 (86.30–108.70) 93.65 (83.90–103.20) 0.0632
  < 65% pred, n/N (%) 8 (2.64) 3 (2.65) 5 (2.63) 0.9902
 FRC (l) % predicted 95.15 (83.30–110.40) 102.60 (86.90–112.40) 93.00 (82.50–107.10) 0.005
 RV/TLC, % 31.34 (27.90–34.57) 31.61 (27.37–34.99) 31.26 (27.92–34.48) 0.8009
 FRC/TLC, % 53.73 (47.96–59.48) 55.42 (49.91–62.09) 52.58 (47.19–58.19) 0.0007
Diffusion capacity (n = 200), median (IQR)
 DLCO, mmol/min/kPa 7.16 (6.39–8.42) 7.05 (6.34–8.35) 7.20 (6.43–8.43) 0.8478
 DLCO% predicted 84.60 (76.90–95.00) 84.20 (76.30–94.60) 84.80 (77.60–95.10) 0.5984
  < 80% pred, n/N (%) 100 (43.48) 41 (47.67) 59 (40.97) 0.3212
 DLCO/VA, mmol/min/kPa/l 1.57 1.42–1.73) 1.53 (1.42–1.71) 1.58 (1.42–1.75) 0.9874
 DLCO/VA% predicted 91.40 (81.50–100.40) 90.70 (81.00–98.10) 91.80 (81.70–101.00) 0.3789
  < 80% pred, n/N (%) 58 (29.15) 23 (30.67) 35 (28.23) 0.7135
Distance walked in 6 min, median (IQR), m 555.00 (516.00–591.00) 564.00 (525.00–603.00) 549.50 (514.00–582.00) 0.0435
 Percentage of predicted value, % 87.00 (81.00–94.00) 86.00 (81.00–94.00) 87.00 (81.00–94.00) 0.8173
 Less than lower limit of the normal range 58 (19.4) 23 (20.4) 35 (18.8) 0.8610

Data are presented as median (interquartile range, IQR) for continuous variables and n (%) for categorical variables. Kruskal-Wallis (K-W) test was used for continuous variables and chi-square test or Fisher’s exact test for all categorical variables. DLCO was measured through single-breath method

HCWs health care workers, IQR interquartile range, BMI body mass index, FEV1 forced expiratory volume in 1 s, VC vital capacity, FVC forced vital capacity, PEF peak expiratory flow, MEF maximal expiratory flow, TLC total lung capacity, RV residual volume, FRC functional residual capacity, SB single-breath method, DLCO diffusing capacity of the lung for carbon monoxide, VA alveolar ventilation